Options Brief: Clinical Data, Inc. (CLDA)

Shares of Clinical Data, Inc. CLDA are higher on the session by 57.49%, trading at $23.67. Overall call volume is now running at 9.12x the daily average, with 25% of all calls traded being purchases on the offer. 25,695 contracts have traded on the session so far. Clinical Data, Inc. is focused on the development and commercialization of therapeutics, with two compounds in the areas of central nervous system and cardiovascular disorders.